Showing results (2131-2140 of 2,211) with videos related to

Sort By:
Pageof 222
BMJ Open|September 24, 2018
Multicentred randomised controlled trial of an augmented exercise referral scheme using web-based behavioural support in individuals with metabolic, musculoskeletal and mental health conditions: protocol for the e-coachER trialWendy Ingram, Douglas Webb, Rod S Taylor, et al.
Plos One|October 8, 2010
Genome-wide DNA methylation maps in follicular lymphoma cells determined by methylation-enriched bisulfite sequencingJeong-Hyeon Choi, Yajun Li, Juyuan Guo, et al.
The Journal of Infectious Diseases|September 4, 2004
Immune responses to Bacillus anthracis protective antigen in patients with bioterrorism-related cutaneous or inhalation anthraxConrad P Quinn, Peter M Dull, Vera Semenova, et al.
The Australian and New Zealand Journal of Psychiatry|February 16, 2013
Biomarkers in bipolar disorder: a positional paper from the International Society for Bipolar Disorders Biomarkers Task ForceBenicio N Frey, Ana C Andreazza, Josselin Houenou, et al.
The American Journal of Clinical Nutrition|September 4, 2024
Clinical and biochemical responses to treatment of uncomplicated severe acute malnutrition: a multicenter observational cohort from the OptiDiag studyLishi Deng, Alemayehu Argaw, Benjamin Guesdon, et al.
Journal of Affective Disorders|June 12, 2024
Depression-Anxiety Coupling Strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study reportAbraham Nunes, Barbara Pavlova, Jasmyn E A Cunningham, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 11, 2020
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif MajeurJennifer Swainson, Alexander McGirr, Pierre Blier, et al.
NPJ Precision Oncology|July 18, 2024
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumabHelen Gogas, Shruthi Ravimohan, Antara Datta, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 28, 2024
Atypical Brain Aging and Its Association With Working Memory Performance in Major Depressive DisorderNatalie C W Ho, Richard A I Bethlehem, Jakob Seidlitz, et al.
NPJ Precision Oncology|August 6, 2021
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumorsAaron S Mansfield, David S Hong, Christine L Hann, et al.
Pageof 222